ACTO today announced it expanded its product partnership with Veeva by joining the Veeva AI Partner Program to help advance the use of Generative AI (GenAI) in life sciences. ACTO offers GenAI products that help field-based representatives with messaging during face-to-face interactions with healthcare providers (HCPs). “The vast amount of information and materials that pharma field teams must understand and use can make it challenging to remember key talking points or quickly respond to questions during HCP...